| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, April 2008, p. 1503-1505, Vol. 52, No. 4
0066-4804/08/$08.00+0 doi:10.1128/AAC.01129-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Service of Microbiology, Hospital Universitario Marqués de Valdecilla,1 and Department of Molecular Biology, School of Medicine, Santander, Spain2
Received 27 August 2007/ Returned for modification 8 November 2007/ Accepted 20 January 2008
The activities of tigecycline and eight other agents were evaluated against 220 coryneform bacteria and 42 Listeria monocytogenes isolates. All strains were inhibited by tigecycline at 0.5 µg/ml, except for 11 Corynebacterium striatum strains that were inhibited at 1 µg/ml. Tigecycline shows good in vitro activity against coryneform bacteria and L. monocytogenes.
Published ahead of print on 28 January 2008.
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |